Expanding donor candidate base for transplantation

transplantation 

Centre of Excellence for Cellular Therapy

Dr Denis Claude Roy and the Centre of Excellence for Cellular Therapy are pivotal in the development of Kiadis Pharma’s ATIR™. This is a novel immunotherapeutic strategy for 40% of patients who suffer from blood cancer and who do not have a standard of care stem cell donor available. ATIR™ enables hematopoietic stem cell transplantations using partially mismatched family members as donors to address this unmet medical need.

Share

Helpdesk

You have questions regarding your health, or the health of a loved one, wondering what cell therapy or regenerative medicine can do for you? Looking for solutions for your research projects? We can put the strength of our network at your service. Write to us!

Question

All clinics around the world offering stem cell treatments are safe.